AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Implementing Procalcitonin in a Community-Based Teaching Hospital

  • Credit:1.0 ACCENT Credits
  • Duration: 1 Hour
  • Date:OCT.29.2019 1:00 PM - 02:00 PM

Price: $0.00

Member Price: $0.00

Rating: Member Average


B·R·A·H·M·S PCT (Procalcitonin) can be a beneficial marker for differentiating microbial etiology versus other causes for inflammatory reactions and as an aid in antibiotic stewardship.  Mounting evidence of procalcitonin’s value coupled with the FDA’s approval of automated assays has allowed for the implementation of these assays in hospitals of all sizes.  Join Jessica Krochmal, MD and Kari Murad, PhD as they describe their experiences of bringing this assay into a smaller, community-based teaching hospital.


  • Review the regulation and kinetics of procalcitonin during infection and sepsis.
  • Summarize the implementation strategy.
  • Understand the implementation process and how success is closely tied to education and physician engagement.
  • Review the strengths of case review and feedback to clinical teams to ensure proper test utilization.


Jessica Diane KorchmanJessica Diane Krochmal, MD
Chair, Department of Pathology
Berkshire Health Systems
Pittsfield, MA

Kari L. MuradKari L. Murad, PhD
Clinical Chemist of Laboratory Services
Berkshire Health Systems
Pittsfield, MA


Thermo Fisher logo